Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Saavedra

Showing results (241-250 of 260) with videos related to

Pageof 26
Sort By:
Rheumatology (Oxford, England)|August 3, 2022
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-surveyAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology International|June 14, 2023
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-surveySilvia Grignaschi, Minchul Kim, Giovanni Zanframundo, et al.
Rheumatology International|March 31, 2023
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) surveyR Naveen, Darpan R Thakare, Masataka Kuwana, et al.
Reumatologia Clinica|April 12, 2026
Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registryLuis Francisco Valdés Corona, Ana González Andrade, Aylin Luna Salazar, et al.
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|September 5, 2023
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported surveySakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Nature Communications|July 22, 2025
Quantitative evaluation of methods to analyze motion changes in single-particle experimentsGorka Muñoz-Gil, Harshith Bachimanchi, Jesús Pineda, et al.
Rheumatology Advances in Practice|March 25, 2024
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-surveyAkira Yoshida, Yuan Li, Vahed Maroufy, et al.
Pageof 26

Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Rheumatology (Oxford, England)|August 3, 2022
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-surveyAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology International|June 14, 2023
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-surveySilvia Grignaschi, Minchul Kim, Giovanni Zanframundo, et al.
Rheumatology International|March 31, 2023
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) surveyR Naveen, Darpan R Thakare, Masataka Kuwana, et al.
Reumatologia Clinica|April 12, 2026
Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registryLuis Francisco Valdés Corona, Ana González Andrade, Aylin Luna Salazar, et al.
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|September 5, 2023
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported surveySakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Nature Communications|July 22, 2025
Quantitative evaluation of methods to analyze motion changes in single-particle experimentsGorka Muñoz-Gil, Harshith Bachimanchi, Jesús Pineda, et al.
Rheumatology Advances in Practice|March 25, 2024
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-surveyAkira Yoshida, Yuan Li, Vahed Maroufy, et al.
Pageof 26